Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Performance and challenges of malaria rapid diagnostic tests in endemic regions of Africa. [PDF]
Ojeniyi FD +7 more
europepmc +1 more source
Diagnostic tests for urinary tract infections and antimicrobial resistance-a reality check between diagnostic innovation and implementation: a critical narrative review. [PDF]
Mohan V, Mitsakakis K.
europepmc +1 more source
Accuracy of recording and reporting of malaria rapid diagnostic tests in Nigeria. [PDF]
Atobatele S +20 more
europepmc +1 more source
Open Diagnostic Reader (ODR): An affordable, modular 3D-printed platform for standardized imaging and quantitative analysis of rapid diagnostic tests. [PDF]
Rogers E +20 more
europepmc +1 more source
Correction to 'Seroprevalence Screening of Chronic Aspergillus Infection in a Post-Tuberculosis Cohort in Senegal: A Cross-Sectional Study Comparing ELISA and Rapid Diagnostic Tests'. [PDF]
europepmc +1 more source

